ArticleHepatology international2025

Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus.

Suixing Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.